Neurocrine Bio. (NBIX) PT Raised to $119 at Mizuho Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 164.85 +19.50 (13.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.35 | 52 Week High | $58.46 | |||
| Open | $159.00 | 52 Week Low | $31.25 | |||
| Day High | $169.53 | P/E | N/A | |||
| Day Low | $157.91 | EPS | $-0.69 | |||
| Volume | 4,056,353 | |||||
